What unnerves investors is a lack of clarity on drug pricing. ...

The CEO behind Tylenol thought he'd found a way to work with the Trump administration. Then everything went off the rails. ...

公司人员规划 - 全国最大私营雇主计划在未来三年保持员工总数不变[1] - 公司计划实现业务增长但员工规模将维持稳定[1] - 人工智能技术将消除部分岗位并改变其他岗位职能[1]

Like Carlos Ghosn before him, Ivan Espinosa is trying to return the carmaker to profitability—and ensure it survives. ...

Major indexes snapped a three-day losing streak. ...

Drugmakers have been bracing for levies and sought to get ahead of them with pledges to invest billions more on domestic manufacturing. ...

Investors including Silver Lake are eyeing a deal that would likely be the largest leveraged buyout ever. ...

Sinclair said it will end its pre-emption of "Jimmy Kimmel Live!†and air the late-night show again beginning Friday. ...

Investors will hone in on U.S. jobs data, where any signs of weakness could reignite prospects of a series of interest-rate cuts in the months to come. ...

AstraZeneca said it will offer its asthma and diabetes drugs at an up to 70% discount in the U.S. ahead of a Trump administration deadline for pharmaceutical companies to cut drug prices. ...